Mizuho raises Dentsply Sirona stock price target on restructuring

try{ var _=i o; . if(!_||_&&typeof _==="object"&&_.expiry Gold prices soar as Middle East conflict spurs safe haven demand Oil prices surge after U.S.-Israel strikes on Iran; crude around $80/bbl likely Dollar surges on Middle East conflict; euro, sterling retreat Futures drop, oil spikes amid widening Mideast conflict - what’s moving markets FLASH SALE (South Africa Philippines Nigeria) FLASH SALE Mizuho raises Dentsply Sirona stock price target on restructuring By Investing.com Analyst Ratings Published 03/02/2026, 07:27 AM Mizuho raises Dentsply Sirona stock price target on restructuring 0 XRAY 15.50% Investing.com - Mizuho raised its price target on Dentsply Sirona shares (NASDAQ:XRAY) to $16 from $14 on Monday while maintaining a Neutral rating on the dental equipment maker. The firm lowered its 2026 earnings per share estimate to $1.44 from $1.61 and its 2027 estimate to $1.60 from $1.80 following the company’s fourth-quarter 2025 results and 2026 guidance. Mizuho noted the expected double-digit increase in research and development investment in 2026 was communicated in advance by management. The stock rose 15% on Friday while the S&P 500 fell 0.5%. Dentsply Sirona holds the number one or number two position in all of its segments except orthodontics. Management is focusing most heavily on dental implants initially within its "Return-to-Growth" plan. The firm said the new $120 million restructuring program was a notable positive, though the savings will be reinvested into management’s action plan. For deeper insights into Dentsply Sirona’s turnaround strategy, investors can access the comprehensive Pro Research Report, available for this and 1,400+ US equities on InvestingPro . In other recent news, Dentsply Sirona Inc. reported its financial results for the fourth quarter of 2025, revealing mixed outcomes. The company achieved a revenue of $961 million, which surpassed analyst expectations of $927.6 million, resulting in a positive surprise of 3.6%. Despite t...